Safety and Efficacy of a DNA Oligonucleotide Therapy in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Resource Type
- Article
- Source
- In
Clinical Lymphoma, Myeloma and Leukemia January 2022 22(1):52-59 - Subject
- Language
- ISSN
- 2152-2650